Dr Angus Robin Bradford VTS Feb 18 th 2014 (with some slides from Dr Tim Williams and Dr F Cole)

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

What Analgesics? Paracetamol – Aspirin Nefopam NSAIDS Opioids
September 5 th – 8 th 2013 Nottingham Conference Centre, United Kingdom
Clinical Case Studies Developed by Dr. David Hunt.
Basics of Pain Management Dr. Allistair Dodds Dept. Pain Medicine Sunderland Royal Hospital July. 07 July. 07 Dr. Allistair Dodds Dept. Pain Medicine Sunderland.
ACUTE CANCER PAIN Dr Mike Bennett Senior Clinical Lecturer in Palliative Medicine St Gemma’s Hospice and University of Leeds.
The purpose is not to imply everyone on controlled substances will become addicted!!! Everyone on controlled substances is, however, at increased risk.
Sublingual Buprenorphine and Pain
Guidelines for Pain Management Paula Wilkinson Chief Pharmacist NHS Mid-Essex.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 05: Relieving Pain and Providing Comfort.
Pain management. Learning objectives At the end of the workshop you will be able to: Consider the important principles of pain and pain management Use.
Pharmacologic Treatment of Post-Herpetic Neuralgia (PHN)
Pain Guidelines Ipswich & East Suffolk CCG 16 January 2014 Mike Bailey Ipswich Hospital Pain Clinic.
USES OF OPIODS IN CHRONIC NON CANCER PAIN (ARTICLE REVIEW)
August 16, 2015 Equianalgesia Opioid Calculator: JHH Applications Suzanne A Nesbit, PharmD, CPE Clinical Pharmacy Specialist, Pain Management Department.
Pethidine: Gap Between Evidence and Practice Professor Richard Day Dept of Clinical Pharmacology and Toxicology St Vincent’s Hospital, Sydney Prepared.
Pain management for AKT NICE guidelines: Neuropathic pain Opioid conversion Controlled drugs.
Step two: Moderate pain Tramadol Opioid combinations Acetaminophen or aspirin with Codeine Hydrocodone Oxycodone Plus/minus adjuvants Dose limiting toxicity.
Opioid Use in Work-related Injuries Pacific Northwest Chapter - Association of Occupational Health Professionals (AOHP) January 4, 2011 Jaymie Mai, PharmD.
B ENZODIAZEPINE DEPENDENCE. WHO - ICD 10 C RITERIA FOR S UBSTANCE D EPENDENCE A definite diagnosis of dependence syndrome should usually be made only.
Opiates in Chronic Pain Dr S Vas, Barnsley VTS October 2014.
 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.
Medications for Pain: What You Need to Know for Treatment in Workers’ Compensation Suzanne Novak, MD, PhD 5/17/07.
Prescribing to Drug Users Dr Iain Brew Medical Officer HMP Leeds November 2010.
Pain Management Laura Bergs FNP. Definition of Chronic Pain Anyone with pain greater than 3 months Anyone with pain greater than 3 months Pain An unpleasant.
PATIENT CASE Module 4 Date of preparation: June 2015 HQ/EFF/15/0024h.
 Methadone is prescribed to relieve moderate to severe pain that has not been relieved by non-narcotic pain relievers.
OPIOIDS IN NON MALIGNANT PAIN CONDITIONS DR JONATHAN TRING.
Problem Behaviors Norman Wetterau. Less serious Ran of out pills three days early After one year lost pills Had a headache and a friend gave her a vicodin.
Katy Trinkley, PharmDAngie Thompson, PharmD.  Opioid risks and risk prevention strategies  Medication treatment by pain type  Fundamental principles.
Opioids plus adjuvants for cancer pain: systematic review Mike Bennett Professor of Palliative Medicine Lancaster University, UK.
Palliative Care In Heart Failure Dr Chi-Chi Cheung Consultant in Palliative Medicine 19 th March 2015.
Pain II: Cancer Pain Management Dr. Leah Steinberg.
FDA Anesthetic & Life Support Drugs Advisory Committee Sept. 10, 2003 Art Van Zee,MD St. Charles Clinic St. Charles, Va.
Let’s Talk About Pain Karen Cox-Seignoret M.B.,B.S., M.R.C.G.P.
Dr Barbara Downes June Introduction Patient group An over view of managing pain Revision of the basics Case examples Drugs and conversions in the.
Safe Opioid Prescribing MedicinesDoseFrequencyRouteQuantity Morphine Sulphate MR 10mg tablets10mgBD OralSupply 28 tablets (Twenty eight tablets) Morphine.
Pain Ladder and Opiate Conversion Christopher Haigh Medicines Optimisation Pharmacist Bolton CCG.
Top Tips in Palliative Care Dr Claire Curtis (in collaboration with the Worcestershire Specialist Palliative Care Teams) Nov 2012 Click to continue.
Chronic Pain Management Harald Lausen, DO, MA FCM Clerkship SIU School of Medicine.
GP Clinical Governance Meeting 13 th of July 2011 Dr Marion Lieth Consultant in Palliative Medicine, Bolton Hospital and Bolton Hospice Common issues:
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
Clinical Knowledge Summaries CKS Analgesia – mild to moderate pain Prescribing analgesics for mild to moderate pain in adults and children. Educational.
Opiates.
Medications for Spine Pain
Bone Pain: A Practical Approach to Management
List Three Mechanisms by which Chronic Opioid Therapy Can Worsen Pain
Opiod analgesics 9월 흉부외과 인턴 김영재.
Opioids for the management chronic non-cancer pain in Primary Care:
Opioids for chronic non-cancer pain? Which ones.....if any?
Larry Halverson, MD Gabrielle Curtis, MD Cox FMR Springfield MO
Pharmacotherapy Eric J. Visser.
Section IV: Principles of Pain Management
Opioids Aware A resource for patients and HCPs to support prescribing of opioid medicines for pain Sue Mulvenna CDAO NHSE S SW March 2016.
Palliative Care in the Outpatient Setting: Pain Management
STOP! Safe Treatment of Pain
A Recommendation from Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from ACOP and APS By Rhys Dela Cruz, Angela Hickey,
Chapter 15 D.3: Opiates Potent medical drugs prepared by chemical modification of natural products can be addictive and become substances of abuse.
Quality Prescribing for Chronic Pain – An Introduction
CH 20: PAIN NATIONAL DEPARTMENT OF HEALTH PRIMARY HEALTHCARE 2014
Pain Management: Patients Maintained on Buprenorphine
THE MODERN MANAGEMENT OF PAIN IN PALLIATIVE MEDICINE
Wider effects In any event, the incident itself is often quite small (and completely avoidable if you follow sops and concentrate (your reported learning)
How do I manage pain and agitation?
Background Cancers are among the leading causes of morbidity and mortality worldwide, responsible for 18.1 million new cases and 9.6 million deaths in.
Essentials of Good Pain Care: A Team-Based Approach
Persistent pain management An update
Tramadol/Paracetamol Fixed-dose Combination in the Treatment of Moderate to Severe Pain Joseph V Pergolizzi Jr, Mart van de Laar, Richard Langford, Hans-Ulrich.
Pain Management Top 10 Resident Pitfalls- 2019
Presentation transcript:

Dr Angus Robin Bradford VTS Feb 18 th 2014 (with some slides from Dr Tim Williams and Dr F Cole)

WHO pain ladder Was designed for cancer pain. Methadone was initially planned, morphine in the end.... Gives us ‘permission’ to escalate doses v quickly – or so it seems. Doesn’t remind us about topical things or neuropathic agents.

“But the drugs don’t work Dr...”

Expect analgesic failure; pursue analgesic success (BMJ 8 th June 2013, page 19-21) Most analgesics don’t work for most people, when you define ‘work’ as a 50% reduction (NNT...) Most studies in acute post-op pain...so useless in the vast majority of patients. Very few studies beyond 12 weeks.

DrugNNTNNH minorNNH major TCA Gabapentin Pregabalin Opioids Tramadol PHN Medications: NNT, NNH NNT number needed to treat, NNH number needed to harm Wu CL, Raja SN. J Pain 2008

In low back pain tapentadol has a 90% failure rate (to give 50% relief) and oxycodone has a 100% failure rate. This is consistent with observations of other opioids and what we see in the pain rehab ‘living with pain’ team.

When they do work they improve sleep, mood, fatigue, QoL, etc (unsurprisingly). If one drug in a class fails, others may not, so we don’t know the best order to try drugs which mainly fail. Due to low success rates, is polypharmacy the answer? (can of worms time....serotonin syndrome, etc). A 50% pain reduction in a small group of patients is worth seeking out....

Expect modest benefits and frame patient expectations of analgesia benefits more realistically Mention relaxation therapies as useful tools in setbacks / flare-ups All the meds can help, but nowhere near as much as pharma wants us to think

Before you start opioids Be aware safety and efficacy of long term opiates is uncertain. Be aware of BPS guidance. Do a comprehensive Pain assessment Including…….The meds they’ve tried (and how long for – actually go through the records) Co-morbid conditions GOALS and WIDER PLAN

There is no evidence from RCTs to support that benefits of long term opioid therapy outweigh the risks.

Starting Opioids Discuss well established side effects Appropriate preparation Long-acting Dose Never injectable (rarely short-act) Start low and go slow (<120mg/day) Co prescribe anti-emetic + laxative Agree follow up interval (1-2 weeks, then monthly) Same prescriber ideally Consider a contract

Opiate Adverse Effects 80% will experience side effects constipation nausea/vomiting itch dizziness sedation (driving?)...anecdote re: bus driver Long term immunological/endocrine effect Addiction, dependence. “Using for sleep Dr” Withdrawal (sweat/cramps/yawn/tremor) Opioid induced hyperalgesia is rare, but real.

Hormonal disturbance GnRH reduced and subsequent effects on FSH/LH levels. Leads to androgen/oestrogen level changes. Prolactin possibly increased. TFTs seem unaffected. Worsens diabetes, worsens obesity (multifactoral).

Mortality data In the US opioid related deaths rose from 4041 in 1999 to in This is more than road traffic accidents. In the UK deaths from prescribed opioids roughly doubled between

Approximate equivalent doses N.B. There is no universal agreement 24 hour doseMorphine equivalent per day Codeine240 mg40mg (26 – 60) Dihydrocodeine240 mg50mg Tramadol400 mgUp to 120mg Oxycodone20mg40mg

Oral Morphine (mg/24hrs) TransdermalBuprenorphine(µg/hr) TransdermalFentanyl(µg/hr) Dose Equivalents

Managing established patients Regular review (monthly/6monthly) to include…..effectiveness side effects plan compliance progression to goals clear documentation Alternatives for ‘flare-up’ management. Ideally this is where ‘compassion days’ come in....pacing skills.

Flare-Up Management Establish ‘flare-up’ and not new pain Re-assurance that will settle Consider short- term changes to other analgesics or use of alternatives E.g. TNS, relaxation techniques, pacing activities, self-compassion!(DWP not keen on this) Avoid dose escalation....A&E struggle with this.

Stopping Opiates – When and How When?Patient’s pain and function not improved, or is worse. Concerns over addictive behaviour. Unacceptable adverse effects. Patient preference. How?Slow/gradual dose reduction Consider other pain relieving strategies.

The future of opioid management (is it nearly now?)

Other tests to be considered in patients on long term opioid therapy.... Blood tests may include:  U&E’s  FBC  LFT  CRP  TFT’s  Testosterone and oestradiol levels  LH  FSH  SHBG  DHEA (an androgen)  Ca²⁺  Mg²⁺  ESR  VitD  Bone profile cost?

So what about GP now? Tramadol KPPI in Bradford and Airedale Tramadol is an opioid analgesic indicated for moderate to severe pain. Tramadol is a potent drug; at 200mg/day it is equivalent to 40mg of oral morphine in 24hrs. Tramadol is available as 12-hourly and 24-hourly modified release preparations. These preparations are significantly more expensive than the immediate release formulations and restrict the up or down titration of the analgesic according to the patient’s symptoms. All patients who are prescribed analgesics should have their pain symptoms and treatment reassessed on a regular basis.

Summary We need patients to know that the medicines will probably help less than we thought. We need to give them more information and review pain medicines better. We need to believe that other methods of dealing with chronic pain help and take the time to encourage a patients to engage with this.

BPS guidance Summary page: f f Patients version: